C
Merck & Co., Inc. MRK
$115.61 -$0.30-0.26% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2025 09/30/2025 06/30/2025 03/31/2025 12/31/2024
Net Income -20.84% 83.24% -18.85% 6.66% 405.30%
Total Depreciation and Amortization 27.29% -4.19% -0.19% 15.13% 23.37%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 77.46% -115.59% -52.34% -90.52% 5.41%
Change in Net Operating Assets -25.01% -49.11% -123.22% -9.76% -1,388.19%
Cash from Operations -17.19% -15.81% -41.58% -19.09% 1,302.44%
Capital Expenditure -10.25% -26.05% 3.41% -54.24% 5.26%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -502,000.00% -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 75.05% 148.76% 97.84% -168.83% -148.46%
Cash from Investing -675.69% 92.64% 27.97% -8.07% -2,824.53%
Total Debt Issued -- 597,800.00% -98.67% -- --
Total Debt Repaid 99.63% -- -- -232.89% -17,866.67%
Issuance of Common Stock 291.67% 180.00% -83.56% -78.16% 100.00%
Repurchase of Common Stock -156.03% -197.97% -435.86% -854.10% -24.43%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -3.43% -3.99% -4.58% -5.13% -5.35%
Other Financing Activities 388.10% 106.25% 11.82% 23.08% -1,300.00%
Cash from Financing 257.89% 208.78% -392.43% -104.51% -34.03%
Foreign Exchange rate Adjustments 106.27% -96.60% 556.10% 213.04% -297.31%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -160.58% 207.30% -111.56% -270.44% 22.16%